Final Exam Part 3 (201-261)

40 Questions | Total Attempts: 49

SettingsSettingsSettings
Please wait...
DNA Quizzes & Trivia

Final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261)


Questions and Answers
  • 1. 
    Newly released RBCs into the blood that still contain some nuclear DNA
    • A. 

      Anisocytosis

    • B. 

      Reticulocytes

    • C. 

      Hematologists

    • D. 

      Erythroblast

    • E. 

      Poikilocytosis

  • 2. 
    Specialists who evaluate the cellular elements of blood microscopically and analytically
    • A. 

      Anisocytosis

    • B. 

      Reticulocytes

    • C. 

      Hematologists

    • D. 

      Erythroblast

    • E. 

      Poikilocytosis

  • 3. 
    Large engulfing cells in the tissues that came from monocytes
    • A. 

      Megakaryocyte

    • B. 

      Nongranulocytes

    • C. 

      Myeloblast

    • D. 

      Polymorphonuclear

    • E. 

      Macrophages

  • 4. 
    Many shaped nucleus or “seg”
    • A. 

      Megakaryocyte

    • B. 

      Nongranulocytes

    • C. 

      Myeloblast

    • D. 

      Polymorphonuclear

    • E. 

      Macrophages

  • 5. 
    Thrombin
    • A. 

      Activates prothrombin to become thrombin

    • B. 

      The final sticky, stringy product of coagulation

    • C. 

      Activates fibrinogen to become fibrin

    • D. 

      A natural anticoagulant that prevents excessive clotting

    • E. 

      A moving clot

  • 6. 
    Thromboplastin
    • A. 

      Activates prothrombin to become thrombin

    • B. 

      The final sticky, stringy product of coagulation

    • C. 

      Activates fibrinogen to become fibrin

    • D. 

      A natural anticoagulant that prevents excessive clotting

    • E. 

      A moving clot

  • 7. 
    Bilirubin
    • A. 

      Condition in which the red blood cell or hemoglobin levels are below normal

    • B. 

      A molecule that has a reddish pigment and is capable of carrying oxygen

    • C. 

      A by-product of RBC breakdown that is sent to the liver

    • D. 

      Protein portion of the hemoglobin molecule

    • E. 

      Iron portion of hemoglobin molecule

  • 8. 
    Anemia
    • A. 

      Condition in which the red blood cell or hemoglobin levels are below normal

    • B. 

      A molecule that has a reddish pigment and is capable of carrying oxygen

    • C. 

      A by-product of RBC breakdown that is sent to the liver

    • D. 

      Protein portion of the hemoglobin molecule

    • E. 

      Iron portion of hemoglobin molecule

  • 9. 
    Hemoglobin
    • A. 

      Condition in which the red blood cell or hemoglobin levels are below normal

    • B. 

      A molecule that has a reddish pigment and is capable of carrying oxygen

    • C. 

      A by-product of RBC breakdown that is sent to the liver

    • D. 

      Protein portion of the hemoglobin molecule

    • E. 

      Iron portion of hemoglobin molecule

  • 10. 
    hematocrit tube layers : buffy layer  ??
    • A. 

      Label A

    • B. 

      Label B

    • C. 

      Label C

    • D. 

      Label D

    • E. 

      Label E

  • 11. 
    Plasma
    • A. 

      Label A

    • B. 

      Label B

    • C. 

      Label C

    • D. 

      Label D

    • E. 

      Label E

  • 12. 
    Select A
    • A. 

      A

    • B. 

      A

  • 13. 
    Select A
    • A. 

      A

    • B. 

      A

  • 14. 
    Select A
    • A. 

      A

    • B. 

      A

  • 15. 
    Select A
    • A. 

      A

    • B. 

      A

  • 16. 
    Select A
    • A. 

      A

    • B. 

      A

  • 17. 
    RBC layer
    • A. 

      Label A

    • B. 

      Label B

    • C. 

      Label C

    • D. 

      Label D

    • E. 

      Label E

  • 18. 
    Air
    • A. 

      Label A

    • B. 

      Label B

    • C. 

      Label C

    • D. 

      Label D

    • E. 

      Label E

  • 19. 
    ESR
    • A. 

      16 to 18 sec or 2.0 to 2.5 INR

    • B. 

      0 to 20 mm/hour

    • C. 

      12 to 18 gm/dL

    • D. 

      36% to 55%

  • 20. 
    ProTime
    • A. 

      16 to 18 sec or 2.0 to 2.5 INR

    • B. 

      0 to 20 mm/hour

    • C. 

      12 to 18 gm/dL

    • D. 

      36% to 55%

  • 21. 
    HemataSTAT
    • A. 

      Coagulation test

    • B. 

      Sedimentation rate

    • C. 

      Complete blood count

    • D. 

      Hematocrit

    • E. 

      Hemoglobin

  • 22. 
    ProTime
    • A. 

      16 to 18 sec or 2.0 to 2.5 INR

    • B. 

      0 to 20 mm/hour

    • C. 

      12 to 18 gm/dL

    • D. 

      36% to 55%

  • 23. 
    HemataSTAT
    • A. 

      Coagulation test

    • B. 

      Sedimentation rate

    • C. 

      Complete blood count

    • D. 

      Hematocrit

    • E. 

      Hemoglobin

  • 24. 
    SEDIPLAST/Westergren
    • A. 

      Coagulation test

    • B. 

      Sedimentation rate

    • C. 

      Complete blood count

    • D. 

      Hematocrit

    • E. 

      Hemoglobin

  • 25. 
    Protime
    • A. 

      Coagulation test

    • B. 

      Sedimentation rate

    • C. 

      Complete blood count

    • D. 

      Hematocrit

    • E. 

      Hemoglobin

  • 26. 
    QBC
    • A. 

      Coagulation test

    • B. 

      Sedimentation rate

    • C. 

      Complete blood count

    • D. 

      Hematocrit

    • E. 

      Hemoglobin

  • 27. 
    Leukopenia
    • A. 

      Abnormal decrease in RBCs

    • B. 

      Abnormal decrease in WBCs

    • C. 

      Cancer of the WBCs

    • D. 

      Abnormal increase in WBCs

    • E. 

      Abnormal increase in RBCs

  • 28. 
    Leukocytosis
    • A. 

      Abnormal decrease in RBCs

    • B. 

      Abnormal decrease in WBCs

    • C. 

      Cancer of the WBCs

    • D. 

      Abnormal increase in WBCs

    • E. 

      Abnormal increase in RBCs

  • 29. 
    Anemia
    • A. 

      Abnormal decrease in RBCs

    • B. 

      Abnormal decrease in WBCs

    • C. 

      Cancer of the WBCs

    • D. 

      Abnormal increase in WBCs

    • E. 

      Abnormal increase in RBCs

  • 30. 
    SMCV (mean cell volume)
    • A. 

      Hgb/HCT (31-37% or gm/dL)

    • B. 

      Hgb/RBC (26-34 pg)

    • C. 

      HCT/RBC (82-98 micrometers/Fl)

  • 31. 
    MCHC (mean cell hemoglobin concentration)
    • A. 

      Hgb/HCT (31-37% or gm/dL)

    • B. 

      Hgb/RBC (26-34 pg)

    • C. 

      HCT/RBC (82-98 micrometers/Fl)

  • 32. 
    MCH (mean cell hemoglobin)
    • A. 

      Hgb/HCT (31-37% or gm/dL)

    • B. 

      Hgb/RBC (26-34 pg)

    • C. 

      HCT/RBC (82-98 micrometers/Fl)

  • 33. 
    Aplastic anemia
    • A. 

      Seen with blood loss (menses, ulcers, hemorrhaging)

    • B. 

      Destruction of circulating RBCs

    • C. 

      Inherited abnormal hemoglobin S

    • D. 

      Caused by decreased vitamin B12

    • E. 

      Destruction of stem cells in bone marrow from toxins

  • 34. 
    Pernicious anemia
    • A. 

      Seen with blood loss (menses, ulcers, hemorrhaging)

    • B. 

      Destruction of circulating RBCs

    • C. 

      Inherited abnormal hemoglobin S

    • D. 

      Caused by decreased vitamin B12

    • E. 

      Destruction of stem cells in bone marrow from toxins

  • 35. 
    Hemolytic anemia
    • A. 

      Seen with blood loss (menses, ulcers, hemorrhaging)

    • B. 

      Destruction of circulating RBCs

    • C. 

      Inherited abnormal hemoglobin S

    • D. 

      Caused by decreased vitamin B12

    • E. 

      Destruction of stem cells in bone marrow from toxins

  • 36. 
    ALL (acute lymphocytic leukemia)
    • A. 

      Sudden cancer of a nongranulocyte

    • B. 

      Presence of atypical “reactive” lymphocytes

    • C. 

      Abnormal decrease of WBCs

    • D. 

      Increase in WBCs (usually due to infection)

    • E. 

      Long-term cancer of granulocytes in bone marrow

  • 37. 
    Leukocytosis
    • A. 

      Sudden cancer of a nongranulocyte

    • B. 

      Presence of atypical “reactive” lymphocytes

    • C. 

      Abnormal decrease of WBCs

    • D. 

      Increase in WBCs (usually due to infection)

    • E. 

      Long-term cancer of granulocytes in bone marrow

  • 38. 
    Leukocytopenia
    • A. 

      Sudden cancer of a nongranulocyte

    • B. 

      Presence of atypical “reactive” lymphocytes

    • C. 

      Abnormal decrease of WBCs

    • D. 

      Increase in WBCs (usually due to infection)

    • E. 

      Long-term cancer of granulocytes in bone marrow

  • 39. 
    CML (chronic myelocytic leukemia)
    • A. 

      Sudden cancer of a nongranulocyte

    • B. 

      Presence of atypical “reactive” lymphocytes

    • C. 

      Abnormal decrease of WBCs

    • D. 

      Increase in WBCs (usually due to infection)

    • E. 

      Long-term cancer of granulocytes in bone marrow

  • 40. 
    Mononucleosis
    • A. 

      Sudden cancer of a nongranulocyte

    • B. 

      Presence of atypical “reactive” lymphocytes

    • C. 

      Abnormal decrease of WBCs

    • D. 

      Increase in WBCs (usually due to infection)

    • E. 

      Long-term cancer of granulocytes in bone marrow